Wealthcare Advisory Partners LLC Blueprint Medicines Corp Transaction History
Wealthcare Advisory Partners LLC
- $3.49 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding BPMC
# of Institutions
379Shares Held
61.6MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$631 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$619 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$529 Million0.06% of portfolio
-
State Street Corp Boston, MA2.5MShares$233 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL1.94MShares$181 Million0.44% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.56B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...